JNJ: Johnson & Johnson Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 355,659.88
Enterprise Value ($M) 363,132.88
Book Value ($M) 68,774.00
Book Value / Share 28.54
Price / Book 5.17
NCAV ($M) -45,289.00
NCAV / Share -18.79
Price / NCAV -7.85

Profitability (mra)
Return on Invested Capital (ROIC) 0.41
Return on Assets (ROA) 0.21
Return on Equity (ROE) 0.53

Liquidity (mrq)
Quick Ratio 0.91
Current Ratio 1.16

Balance Sheet (mrq) ($M)
Current Assets 53,495.00
Assets 167,558.00
Liabilities 98,784.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 85,159.00
Operating Income 22,009.00
Net Income 35,153.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 22,791.00
Cash from Investing 878.00
Cash from Financing -15,825.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.53 -7.07
01-30 13G/A State Street Corp 5.52 -6.64
01-26 13G/A BlackRock Inc. 7.70 -6.28

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ Transition Report Pursuant to Section 13 or
2023-10-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-04-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-16 1,829,374 10,223,217 17.89
2024-04-15 1,161,533 8,502,266 13.66
2024-04-12 857,756 2,006,944 42.74
2024-04-11 1,075,535 2,208,583 48.70

(click for more detail)

Similar Companies
EBS – Emergent BioSolutions Inc. ELAN – Elanco Animal Health Incorporated
HYAC – Haymaker Acquisition Corp. 4 LLY – Eli Lilly and Company
MRK – Merck & Co., Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Johnson & Johnson